Iradimed IRMD
NASDAQ IRMD
$83.41 -0.99 (-1.17%)
As of: Sep 9, 2026 · 3:59 PM EDT

Iradimed (IRMD) EBITDA Margin Growth (1y) (2014 - 2026)

Analysis

Iradimed (IRMD) EBITDA Margin Growth (1y) (2014 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin Growth (1y) (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn -497.00
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn 314.00
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn 124.00
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn 670.00
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn 546.00
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn 264.00
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn -919.00
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn 595.00
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn 146.00
10 Iradimed 1.07 Bn 1.01 Bn 15.16 Mn -203.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -203.00
Mar 31, 2026 509.00
Dec 31, 2025 135.00
Sep 30, 2025 64.00
Jun 30, 2025 187.00
Mar 31, 2025 86.00
Dec 31, 2024 35.00
Sep 30, 2024 -419.00
Jun 30, 2024 62.00
Mar 31, 2024 109.00
Dec 31, 2023 95.00
Sep 30, 2023 496.00
Jun 30, 2023 -198.00
Mar 31, 2023 92.00
Dec 31, 2022 243.00
Sep 30, 2022 252.00
Jun 30, 2022 1,395.00
Mar 31, 2022 571.00
Dec 31, 2021 1,857.00
Sep 30, 2021 1,811.00